Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4-week, randomized, double-blind, placebo-controlled, dose–response study

✍ Scribed by M. Goldberg; Y.-P. Li; J. F. Johanson; A. W. Mangel; M. Kitt; D. T. Beattie; K. Kersey; O. Daniels

• Book ID: 108606078
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 311 KB
• Volume: 32
• Category: Article
• ISSN: 0269-2813
• DOI: 10.1111/j.1365-2036.2010.04456.x